TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Spago Nanomedical AB (publ)
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Turnover |
166
|
108
|
95 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-2,830
|
-3,805
|
-3,522 |
| EBITDA |
-2,908
|
-3,857
|
-3,514 |
| Total assets |
3,446
|
4,775
|
18,507 |
| Current assets |
3,359
|
4,678
|
5,863 |
| Current liabilities |
510
|
1,034
|
791 |
| Equity capital |
2,893
|
3,724
|
17,717 |
| - share capital |
303
|
1,700
|
8,172 |
| Employees (average) |
13
|
13
|
15 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Solvency |
84.0%
|
78.0%
|
95.7% |
| Turnover per employee |
13
|
8
|
6 |
| Profit as a percentage of turnover |
-1704.8%
|
-3523.1%
|
-3707.4% |
| Return on assets (ROA) |
-82.1%
|
-79.7%
|
-19.0% |
| Current ratio |
658.6%
|
452.4%
|
741.2% |
| Return on equity (ROE) |
-97.8%
|
-102.2%
|
-19.9% |
| Change turnover |
62
|
13
|
35 |
| Change turnover % | 59% | 60% | |
| Chg. No. of employees |
0
|
-2
|
-1 |
| Chg. No. of employees % | 0% | -6% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.